BioSpace News Archive

Business

EVERSANA™ appoints seasoned oncology veteran Suzanne Greenwood to commercial leadership team

EVERSANATM, the leading independent provider of global commercial services to the life science industry, today appointed oncology veteran Suzanne Greenwood, RN, BSN, to Senior Vice President, Commercial Solutions.

October 27, 2019
·
2 min read
World Federation of Neurology Reveals New Frontiers in Epilepsy Treatment for Children, Pregnant Women and, New Links Between ADHD and Epilepsy at 24th Annual World Congress of Neurology, Dubai, Oct 27 – 31

The road to caring for patients with epilepsy is leading to more effective options for patients of all ages, according to expert findings unveiled by members of the World Federation of Neurology.

October 27, 2019
·
5 min read
Pharm Country

A single, master switch for sugar levels?

When a fly eats sugar, a single brain cell sends simultaneous messages to stimulate one hormone and inhibit another to control glucose levels in the body.

October 27, 2019
·
3 min read
Drug Development

GeoVax Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV

GeoVax Labs, Inc. announced its participation in a planned clinical trial led by researchers at American Gene Technologies, to develop a therapy aimed at eliminating HIV from infected people..

October 27, 2019
·
4 min read
Pharm Country

Jubilant Awarded Radiopharmaceutical Group Purchasing Agreement by Premier

Jubilant Radiopharma announced today that its Radiopharmacies Division has been awarded the group purchasing agreement by Premier Inc. for its full line of radiopharmaceuticals products.

October 27, 2019
·
2 min read
Merus Bispecific Antibody MCLA-128 Shows Encouraging Early Clinical Activity in Patients with Cancers Harboring NRG1 Gene Fusions

Tumor shrinkage observed in three patients harboring NRG1 fusions (two pancreatic, one non-small cell lung cancer) presented by investigators at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 27, 2019
·
14 min read
Drug Development

Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study of AG-270, a MAT2A Inhibitor, in Patients with MTAP-Deleted Tumors

Plasma SAM Biomarker Indicates Robust Target Engagement at Well Tolerated Doses; AG-270 Maximum Tolerated Dose Determined to be 200 mg Once Daily

October 27, 2019
·
9 min read
Business

ACEP Selects Dr. Mark Rosenberg as President-Elect

The American College of Emergency Physicians named Mark S. Rosenberg, DO, MBA, FACEP as the new president-elect during ACEP19 in Denver Colorado.

October 27, 2019
·
1 min read